Karin E. Lundin

1.6k total citations
51 papers, 1.1k citations indexed

About

Karin E. Lundin is a scholar working on Molecular Biology, Genetics and Ecology. According to data from OpenAlex, Karin E. Lundin has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Ecology. Recurrent topics in Karin E. Lundin's work include RNA Interference and Gene Delivery (29 papers), Advanced biosensing and bioanalysis techniques (28 papers) and DNA and Nucleic Acid Chemistry (20 papers). Karin E. Lundin is often cited by papers focused on RNA Interference and Gene Delivery (29 papers), Advanced biosensing and bioanalysis techniques (28 papers) and DNA and Nucleic Acid Chemistry (20 papers). Karin E. Lundin collaborates with scholars based in Sweden, Denmark and Egypt. Karin E. Lundin's co-authors include Smith Rjh, Olof Gissberg, Roger Strömberg, Jesper Wengel, Rula Zain, Pedro M. D. Moreno, Astrid Gräslund, Liam Good, Eman M. Zaghloul and Fredrik Oftung and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and PLoS ONE.

In The Last Decade

Karin E. Lundin

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin E. Lundin Sweden 19 883 117 100 90 71 51 1.1k
Julien Depollier France 5 918 1.0× 206 1.8× 135 1.4× 49 0.5× 27 0.4× 5 1.1k
Anne M. Doody United States 13 805 0.9× 156 1.3× 108 1.1× 49 0.5× 163 2.3× 14 1.2k
Akiko Matsumura Japan 10 810 0.9× 76 0.6× 160 1.6× 123 1.4× 79 1.1× 29 1.2k
Zihua Zeng United States 19 975 1.1× 121 1.0× 119 1.2× 107 1.2× 30 0.4× 39 1.2k
Sigal Gelkop Israel 14 490 0.6× 172 1.5× 144 1.4× 177 2.0× 53 0.7× 19 987
Kazuyuki Takai Japan 21 1.3k 1.5× 204 1.7× 110 1.1× 102 1.1× 112 1.6× 103 1.6k
Mark W. Bruner United States 12 729 0.8× 146 1.2× 64 0.6× 172 1.9× 49 0.7× 17 936
Peter Järver Sweden 14 832 0.9× 186 1.6× 105 1.1× 26 0.3× 26 0.4× 18 934
Toby Price United Kingdom 9 594 0.7× 167 1.4× 166 1.7× 84 0.9× 82 1.2× 11 906
Beate Müller Germany 7 654 0.7× 89 0.8× 72 0.7× 90 1.0× 68 1.0× 8 1.1k

Countries citing papers authored by Karin E. Lundin

Since Specialization
Citations

This map shows the geographic impact of Karin E. Lundin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin E. Lundin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin E. Lundin more than expected).

Fields of papers citing papers by Karin E. Lundin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin E. Lundin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin E. Lundin. The network helps show where Karin E. Lundin may publish in the future.

Co-authorship network of co-authors of Karin E. Lundin

This figure shows the co-authorship network connecting the top 25 collaborators of Karin E. Lundin. A scholar is included among the top collaborators of Karin E. Lundin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin E. Lundin. Karin E. Lundin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lundin, Karin E., Yi Hao, Samantha Roudi, et al.. (2024). Anti-gene oligonucleotide clamps invade dsDNA and downregulate huntingtin expression. Molecular Therapy — Nucleic Acids. 35(4). 102348–102348. 1 indexed citations
2.
Honcharenko, Dmytro, Karin E. Lundin, Jyotirmoy Maity, et al.. (2022). 2′- O -( N -(Aminoethyl)carbamoyl)methyl Modification Allows for Lower Phosphorothioate Content in Splice-Switching Oligonucleotides with Retained Activity. Nucleic Acid Therapeutics. 32(3). 221–233. 2 indexed citations
3.
Olsson, Thomas, Olof Gissberg, Osama Saher, et al.. (2021). Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System. Nucleic Acid Therapeutics. 31(6). 443–456. 5 indexed citations
4.
Lundin, Karin E., Olof Gissberg, Smith Rjh, & Rula Zain. (2019). Chemical Development of Therapeutic Oligonucleotides. Methods in molecular biology. 2036. 3–16. 11 indexed citations
5.
Xu, You, Olof Gissberg, Jesper Wengel, et al.. (2019). The ability of locked nucleic acid oligonucleotides to pre-structure the double helix: A molecular simulation and binding study. PLoS ONE. 14(2). e0211651–e0211651. 8 indexed citations
6.
Wengel, Jesper, et al.. (2019). Oligonucleotide Binding to Non-B-DNA in MYC. Molecules. 24(5). 1000–1000. 4 indexed citations
7.
Lundin, Karin E., Qing Wang, Per Marits, et al.. (2018). Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report. BMC Pediatrics. 18(1). 285–285. 9 indexed citations
8.
Xu, You, Alessandra Villa, Karin E. Lundin, et al.. (2017). LNA effects on DNA binding and conformation: from single strand to duplex and triplex structures. Scientific Reports. 7(1). 11043–11043. 29 indexed citations
9.
Zaghloul, Eman M., Olof Gissberg, Pedro M. D. Moreno, et al.. (2017). CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression. Nucleic Acids Research. 45(9). 5153–5169. 18 indexed citations
10.
Lundin, Karin E., Olof Gissberg, & Smith Rjh. (2015). Oligonucleotide Therapies: The Past and the Present. Human Gene Therapy. 26(8). 475–485. 210 indexed citations
11.
Wiklander, Oscar P. B., Lilian Larsson, Pedro M. D. Moreno, et al.. (2015). RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form. Journal of Molecular and Cellular Cardiology. 82. 186–193. 16 indexed citations
12.
Lundin, Karin E., Torben Højland, Bo R. Hansen, et al.. (2013). Biological Activity and Biotechnological Aspects of Locked Nucleic Acids. Advances in genetics. 82. 47–107. 84 indexed citations
13.
Zaghloul, Eman M., Andreas S. Madsen, Pedro M. D. Moreno, et al.. (2010). Optimizing anti-gene oligonucleotide ‘Zorro-LNA’ for improved strand invasion into duplex DNA. Nucleic Acids Research. 39(3). 1142–1154. 27 indexed citations
14.
Simonson, Oscar E., Karin E. Lundin, Zhiying Chen, et al.. (2009). Gene Transfer to Mouse Heart and Skeletal Muscles Using a Minicircle Expressing Human Vascular Endothelial Growth Factor. Journal of Cardiovascular Pharmacology. 53(1). 18–23. 19 indexed citations
15.
Viola, Joana R., Hans Leijonmarck, Oscar E. Simonson, et al.. (2009). Fatty acid–spermine conjugates as DNA carriers for nonviral in vivo gene delivery. Gene Therapy. 16(12). 1429–1440. 18 indexed citations
16.
Moreno, Pedro M. D., Małgorzata Wenska, Karin E. Lundin, et al.. (2009). A synthetic snRNA m3G-CAP enhances nuclear delivery of exogenous proteins and nucleic acids. Nucleic Acids Research. 37(6). 1925–1935. 25 indexed citations
17.
Hasan, Maroof, et al.. (2007). Self-Assembling Supramolecular Complexes by Single-Stranded Extension from Plasmid DNA. Oligonucleotides. 17(1). 80–94. 9 indexed citations
18.
Simonson, Oscar E., et al.. (2005). Bioplex Technology: Novel Synthetic Gene Delivery Pharmaceutical Based on Peptides Anchored to Nucleic Acids. Current Pharmaceutical Design. 11(28). 3671–3680. 12 indexed citations
19.
Lundin, Karin E., et al.. (2003). Generation of microglia specific reagents from phage displayed peptide libraries. Journal of Immunological Methods. 278(1-2). 235–247. 3 indexed citations
20.
Lundin, Karin E., Annika C. Karlsson, Anders Nygren, et al.. (1988). Certain Human Gpl20‐HIV Antibodies React with Anti‐CD4 Antibodies. Scandinavian Journal of Immunology. 27(1). 113–117. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Depollier Breakdown of academic impact, for papers by Anne M. Doody Breakdown of academic impact, for papers by Akiko Matsumura Breakdown of academic impact, for papers by Zihua Zeng Breakdown of academic impact, for papers by Sigal Gelkop Breakdown of academic impact, for papers by Kazuyuki Takai Breakdown of academic impact, for papers by Mark W. Bruner Breakdown of academic impact, for papers by Peter Järver Breakdown of academic impact, for papers by Toby Price Breakdown of academic impact, for papers by Beate Müller
Rankless by CCL
2026